Meisner Lara bought BCAX
September 29, 2025 · Form 4 insider transaction
Meisner Lara bought 33,807 shares of Bicara Therapeutics Inc. at $9.24 per share, a transaction worth $312.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
33,807
Price
$9.24
Total value
$312.5K
InsiderMeisner Lara
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 29, 2025
Filing dateOctober 1, 2025
Shares owned after33,807
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.